Arkansas Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Healthcare Report.

Press releases published on August 3, 2026

2 hours ago

Neuronetics and Jorey Chernett Announce Shared Vision

Indeterminate GlobeNewswire

2 hours ago

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

Indeterminate GlobeNewswire

2 hours ago

Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results 

Indeterminate GlobeNewswire

2 hours ago

Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026

Indeterminate GlobeNewswire

2 hours ago

Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases

Indeterminate GlobeNewswire

2 hours ago

Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation

Indeterminate GlobeNewswire

2 hours ago

electroCore to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Indeterminate GlobeNewswire

2 hours ago

Curium Announces Definitive Agreement to Merge with Lantheus

Indeterminate GlobeNewswire

2 hours ago

BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET

Indeterminate GlobeNewswire

2 hours ago

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

2 hours ago

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Indeterminate GlobeNewswire

2 hours ago

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

2 hours ago

Veritasium Goes Behind the Scenes at Kraig Biocraft Laboratories to Explore the Future of Commercial Spider Silk

Indeterminate GlobeNewswire

3 hours ago

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Indeterminate GlobeNewswire

3 hours ago

Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

3 hours ago

Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

Indeterminate GlobeNewswire

3 hours ago

Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia

Indeterminate GlobeNewswire